Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mcpherson’S Limited ( (AU:MCP) ) has issued an announcement.
McPherson’s reported revenue from continuing operations of $66.0 million for the half year to 31 December 2025, a 6.7% decline, but maintained largely stable core brand sales at $61.9 million as Manicare and Swisspers delivered solid growth while Dr LeWinn’s and Fusion Health lagged. The shift to a new operating model reduced fixed costs, lifting underlying EBITDA 10.6% to $2.2 million and supporting a net cash position of $12.6 million, despite a statutory net loss of $2.3 million driven by a non-cash impairment and one-off items.
Management highlighted that the transition to pharmacy wholesalers, SKU rationalisation, and logistics outsourcing caused temporary revenue and supply disruptions, particularly for Dr LeWinn’s and Fusion Health, but said corrective actions and restored stock levels should support gradual improvement in the second half. The board opted against paying a dividend but authorised an on-market share buyback of up to A$2.0 million, signalling confidence in the company’s strategy and the scalability of its new operating model for future growth and shareholder returns.
The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.
More about Mcpherson’S Limited
McPherson’s Limited is an ASX-listed consumer products company focused on health, wellness, and beauty brands sold primarily through pharmacy and grocery channels in Australia and selected international markets. Its core portfolio includes Manicare, Swisspers, Lady Jayne, Dr LeWinn’s, and Fusion Health, which together account for the vast majority of group sales and underpin its market positioning in everyday personal care and skincare categories.
Average Trading Volume: 263,385
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$27.35M
For detailed information about MCP stock, go to TipRanks’ Stock Analysis page.

